CA2182686A1 - Moyen de marquage visuel de tissus corporels - Google Patents

Moyen de marquage visuel de tissus corporels

Info

Publication number
CA2182686A1
CA2182686A1 CA002182686A CA2182686A CA2182686A1 CA 2182686 A1 CA2182686 A1 CA 2182686A1 CA 002182686 A CA002182686 A CA 002182686A CA 2182686 A CA2182686 A CA 2182686A CA 2182686 A1 CA2182686 A1 CA 2182686A1
Authority
CA
Canada
Prior art keywords
marking
colored
bodily tissues
dye
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002182686A
Other languages
English (en)
Inventor
Sylvia Heywang-Kobrunner
Werner Weitschies
Ulrich Speck
Thomas Fritzsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2182686A1 publication Critical patent/CA2182686A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasonic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasonic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3933—Liquid markers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3937—Visible markers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3954—Markers, e.g. radio-opaque or breast lesions markers magnetic, e.g. NMR or MRI
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne l'utilisation de substances colorées destinées à la RMN, la radiographie ou, le cas échéant, de substances destinées à la production d'images par ultrasons, contenant des colorants, pour le marquage de tissus corporels.
CA002182686A 1994-02-03 1995-01-13 Moyen de marquage visuel de tissus corporels Abandoned CA2182686A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4403789.9 1994-02-03
DE4403789A DE4403789A1 (de) 1994-02-03 1994-02-03 Mittel zur visuellen Markierung von Körpergewebe

Publications (1)

Publication Number Publication Date
CA2182686A1 true CA2182686A1 (fr) 1995-08-10

Family

ID=6509687

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002182686A Abandoned CA2182686A1 (fr) 1994-02-03 1995-01-13 Moyen de marquage visuel de tissus corporels

Country Status (5)

Country Link
EP (1) EP0742724A1 (fr)
JP (1) JPH09508397A (fr)
CA (1) CA2182686A1 (fr)
DE (1) DE4403789A1 (fr)
WO (1) WO1995020981A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656450B2 (en) 2000-07-17 2003-12-02 California Institute Of Technology, Inc. Macrocyclic magnetic resonance imaging contrast agents
US6673333B1 (en) 2000-05-04 2004-01-06 Research Corporation Technologies, Inc. Functional MRI agents for cancer imaging
US6713046B1 (en) 1997-10-27 2004-03-30 Research Corporation Technologies Magnetic resonance imaging agents for the delivery of therapeutic agents
US6770261B2 (en) 1995-06-02 2004-08-03 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US7029655B2 (en) 2000-10-04 2006-04-18 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
US7354568B1 (en) 1997-10-27 2008-04-08 California Institute Of Technology Magnetic resonance imaging agents for the detection of physiological agents

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2199864C (fr) 1994-09-16 2006-06-20 Seth A. Foerster Procedes et dispositifs pour delimiter et marquer des tissus corporels
US5900228A (en) 1996-07-31 1999-05-04 California Institute Of Technology Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
US6493570B1 (en) * 1998-11-02 2002-12-10 Photogen, Inc. Method for improved imaging and photodynamic therapy
US6022526A (en) * 1997-07-30 2000-02-08 Pharmacyclics, Inc. Use of texaphyrins in detection of melanin and melanin metabolites diagnostic of melanotic melanoma
US6270464B1 (en) 1998-06-22 2001-08-07 Artemis Medical, Inc. Biopsy localization method and device
US6986740B2 (en) * 1998-11-02 2006-01-17 Xantech Pharmaceuticals, Inc. Ultrasound contrast using halogenated xanthenes
US9669113B1 (en) 1998-12-24 2017-06-06 Devicor Medical Products, Inc. Device and method for safe location and marking of a biopsy cavity
US6356782B1 (en) 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6371904B1 (en) * 1998-12-24 2002-04-16 Vivant Medical, Inc. Subcutaneous cavity marking device and method
DE19925311B4 (de) * 1999-05-27 2004-06-09 Schering Ag Mehrstufen-Verfahren zur Herstellung von gasgefüllten Mikrokapseln
ITMO20010060A1 (it) * 2001-03-30 2002-09-30 H S Hospital Service S R L Metodo e mezzi per l'individuazione e la segnalazione di una lesione non palpabile in tessuti molli

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770261B2 (en) 1995-06-02 2004-08-03 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
US6713046B1 (en) 1997-10-27 2004-03-30 Research Corporation Technologies Magnetic resonance imaging agents for the delivery of therapeutic agents
US7354568B1 (en) 1997-10-27 2008-04-08 California Institute Of Technology Magnetic resonance imaging agents for the detection of physiological agents
US6673333B1 (en) 2000-05-04 2004-01-06 Research Corporation Technologies, Inc. Functional MRI agents for cancer imaging
US6656450B2 (en) 2000-07-17 2003-12-02 California Institute Of Technology, Inc. Macrocyclic magnetic resonance imaging contrast agents
US7029655B2 (en) 2000-10-04 2006-04-18 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits

Also Published As

Publication number Publication date
WO1995020981A1 (fr) 1995-08-10
EP0742724A1 (fr) 1996-11-20
JPH09508397A (ja) 1997-08-26
DE4403789A1 (de) 1995-08-10

Similar Documents

Publication Publication Date Title
CA2182686A1 (fr) Moyen de marquage visuel de tissus corporels
CA2361530C (fr) Procedes et preparations chimiques pour le marquage limite dans le temps de sites de biopsie
US20090285760A1 (en) Method for detecting cancer using icg fluorescence method
EP0194644B1 (fr) Microsphères biodégradables et procédé pour leur préparation
CN109395101A (zh) 靶向血脑屏障和脑胶质瘤的磁共振对比剂的制备方法
JP2001512144A (ja) 組織の潅流の造影剤増強磁気共鳴撮像法
US11730831B2 (en) Imaging agents and methods of using the same
CA2433956A1 (fr) Utilisation de l'imr pour le depistage du cancer de la prostate chez des personnes
CA2433953A1 (fr) Utilisation de l'imr pour le depistage du cancer du sein chez des personnes asymptomatiques a risque normal
US20050171424A1 (en) Methods for imaging the lymphatic system using dendrimer-based contrast agents
CA2692570A1 (fr) Procede de diagnostic et de traitement de tumeurs malignes et composes de marquage
JP2013135801A (ja) センチネルリンパ節内部を描出する画像診断装置及びその作動方法
WO2005017539A2 (fr) Imagerie de pathologies
Li et al. Albumin-based nanoparticle for dual-modality imaging of the lymphatic system
AU2014229811B2 (en) Hypoosmotic solutions for lymph node detection
EP1181570B1 (fr) Procede d'imagerie par resonance magnetique
CN114601938A (zh) 一种引导乳腺癌保乳切缘精准评估的荧光/核磁探针
US20040162479A1 (en) Percutaneous removal of sentinel lymph node using contrast imaging for identification
Miwa et al. ICG fluorescence imaging and its medical applications
Asaki et al. Diagnosis of submucosal tumors by injecting a water soluble contrast medium: Basic research and imaging of tumors
Chen et al. Application of Targeted Nano-Bubble Ultrasound Contrast Agent in the Detection of Arterial Intima Inflammation in Rats
JP3490468B2 (ja) Ｔ２陰性効果を目的とした消化管造影用組成物
JP2009512700A (ja) アポトーシスのインビボ検出
CN118382404A (zh) 一种示踪粒子及其应用和图像处理方法
WO2024183826A1 (fr) Particule de traceur, utilisation correspondante et procédé de traitement d'image

Legal Events

Date Code Title Description
FZDE Discontinued